Is β-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage?

scientific article published on 9 October 2012

Is β-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10072-012-1210-Y
P698PubMed publication ID23053838
P5875ResearchGate publication ID232230493

P2093author name stringBishwanath Kumar
Jayantee Kalita
Usha Kant Misra
P2860cites workbeta Blockade after myocardial infarction: systematic review and meta regression analysisQ24621730
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesQ24658205
The novel beta-blocker, carvedilol, provides neuroprotection in transient focal strokeQ30907682
Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysisQ33226226
Theoretical and experimental optimization of laser speckle contrast imaging for high specificity to brain microcirculationQ33248103
Autonomic nervous system disorders in strokeQ33819547
The effect of pneumonia on mortality among patients hospitalized for acute strokeQ35071558
Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction periodQ35562104
Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulationQ36371682
Inflammation after intracerebral hemorrhageQ36620460
Catecholamine influences and sympathetic neural modulation of immune responsivenessQ40436974
The anatomy and physiology of cortical mechanisms of cardiac controlQ40784121
A study of prognostic predictors of supratentorial haematomasQ40957268
Prognostic relevance of pathological sympathetic activation after acute thromboembolic strokeQ43734075
Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial.Q44972753
Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trialQ46414622
Serum cortisol and outcome of ischemic brain infarctionQ48287883
Cardiac baroreceptor sensitivity is impaired after acute stroke.Q50933715
Beta-blockers reduce the risk of early death in ischemic stroke.Q51484417
Protective effects of beta-blockers in cerebrovascular disease.Q51766779
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin.Q52026372
American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceQ55879451
Middle Cerebral Artery Infarcts Encompassing the Insula Are More Prone to GrowthQ58280573
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsisQ68141412
Acute myocardial and plasma catecholamine changes in experimental strokeQ69531913
The Canadian Neurological Scale: validation and reliability assessmentQ69591988
Plasma norepinephrine in strokeQ70777974
Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortalityQ72808879
Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous systemQ77512461
Grading scale for prediction of outcome in primary intracerebral hemorrhagesQ80019532
Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC scoreQ81461839
Anti-adrenergic medications and edema development after intracerebral hemorrhageQ83291458
P433issue7
P304page(s)1099-1104
P577publication date2012-10-09
P1433published inNeurological SciencesQ15763262
P1476titleIs β-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage?
P478volume34

Reverse relations

cites work (P2860)
Q48133888Beta-blocker therapy is not associated with mortality after intracerebral hemorrhage.
Q38930435Increased infections with β-blocker use in ischemic stroke, a β2-receptor mediated process?
Q28073307Intracerebral Hemorrhage: Perihemorrhagic Edema and Secondary Hematoma Expansion: From Bench Work to Ongoing Controversies
Q37630760Pre-Stroke Use of Beta-Blockers Does Not Lower Post-Stroke Infection Rate: An Exploratory Analysis of the Preventive Antibiotics in Stroke Study
Q33862295Preclinical Studies and Translational Applications of Intracerebral Hemorrhage.
Q37115981β-Blockers associated with no class-specific survival benefit in acute intracerebral hemorrhage

Search more.